EyeConic: Qualification for Cone-Optogenetics
ConditionRetinal Dystrophies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorInstitute of Molecular and Clinical Ophthalmology Basel
About this trial
This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosis of generalized IRD
Low vision as defined as visual acuity worse or equal to 0.05 (or 20/400) in the study eye
Availability of macular optical coherence tomography (OCT)
Normal ophthalmic findings
Disqualifiers
Other eye diseases with a significant effect on vision or retinal structure
Extraocular disease affecting retinal structure such as neurodegenerative diseases
Trial population
* Patients with diagnosis of generalized retinal dystrophy * Normal controls
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Optical coherence tomography (OCT)
Diagnostic testData of macular optical coherence tomography (OCT)
Treatment groups
1,000 Participants
are divided into 2 treatment groupsGroup A: Patients1 intervention
Group B: Controls1 intervention
Trial outcomes
Primary outcomes
1
OCT - Central retinal volume
Number of participants with preserved central retinal volume
Time frame
Baseline (about 10 minutes)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov